Concepedia

In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China

Douglas J. Biedenbach, S. Bouchillon, Brian Johnson, Jeff Alder, D. Sahm

European Journal of Clinical Microbiology & Infectious Diseases · 2016 · 13 citations · 14 references

DOI

References

14

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Mary Jane Ferraro · 2000 · 16.9K citations

, , +5

Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?

Kyle J. Popovich, Robert A. Weinstein, Bala Hota · Clinical Infectious Diseases · 2008 · 377 citations · Full text

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

Gregory J. Moran, Edward Fang, G. Ralph Corey et al. · The Lancet Infectious Diseases · 2014 · 301 citations

, , +8

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey et al. · Antimicrobial Agents and Chemotherapy · 2014 · 140 citations · Full text

, , +17

Tedizolid Phosphate: a Next-Generation Oxazolidinone

Jeffrey M. Rybak, Karrine D. Roberts · Infectious Diseases and Therapy · 2015 · 77 citations · Full text

, , +17